Cite
MLA Citation
G D'Haens et al.. “DOP48 Amiselimod, a selective S1P receptor modulator in Crohn's disease patients: a proof-of-concept study.” Journal of Crohn's and colitis, vol. 13, n.d., pp. S055–S056. http://access.bl.uk/ark:/81055/vdc_100094055373.0x000011